| Brent Thomas Watson, MD | |
|
2132 N 1700 W Ste 230, Layton, UT 84041-7060 | |
| (801) 773-3900 | |
| (801) 773-3900 |
| Full Name | Brent Thomas Watson |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 34 Years |
| Location | 2132 N 1700 W Ste 230, Layton, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225129158 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 187506-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Legacy Healthcare, Inc | Layton, UT | Home health agency |
| Davis Hospital And Medical Center | Layton, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Catholic Health Initiatives Colorado | 8022927342 | 998 |
News Archive
In this post in the Center for Global Development's (CGD) "Rethinking U.S. Foreign Assistance" blog, Connie Veillette, director of CGD's rethinking U.S. foreign assistance initiative, highlights two recent posts by CGD's Amanda Glassman and Nandini Oomman on the future of the Global Health Initiative.
For the most common form of childhood eye cancer, unilateral retinoblastoma, shortening the time from the first appearance of symptoms to diagnosis of disease has no bearing on survival or stage of the disease, according to a study by researchers at Columbia University Mailman School of Public Health in partnership with the Hospital Infantil de Mexico.
Alliance HealthCare Services, Inc.), a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced the acquisition of certain radiation therapy assets from Arkansas Cancer Center, P.A. The purchase price is expected to total approximately $9 million in cash and assumed indebtedness.
Women who receive palbociclib (Ibrance) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic neutropenia (BEN), can safely receive the drug without major concerns of developing infections associated with neutropenia, or low white blood cell counts, say Georgetown Lombardi Comprehensive Cancer Center researchers.
A discovery by University at Buffalo biologists that may explain the evolution of a lethal toxin is providing new information that could lead to more effective treatments for humans who fall victim to it.
› Verified 2 days ago
| Entity Name | Physician Group Of Utah Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477676930 PECOS PAC ID: 8022032234 Enrollment ID: O20060113000886 |
News Archive
In this post in the Center for Global Development's (CGD) "Rethinking U.S. Foreign Assistance" blog, Connie Veillette, director of CGD's rethinking U.S. foreign assistance initiative, highlights two recent posts by CGD's Amanda Glassman and Nandini Oomman on the future of the Global Health Initiative.
For the most common form of childhood eye cancer, unilateral retinoblastoma, shortening the time from the first appearance of symptoms to diagnosis of disease has no bearing on survival or stage of the disease, according to a study by researchers at Columbia University Mailman School of Public Health in partnership with the Hospital Infantil de Mexico.
Alliance HealthCare Services, Inc.), a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced the acquisition of certain radiation therapy assets from Arkansas Cancer Center, P.A. The purchase price is expected to total approximately $9 million in cash and assumed indebtedness.
Women who receive palbociclib (Ibrance) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic neutropenia (BEN), can safely receive the drug without major concerns of developing infections associated with neutropenia, or low white blood cell counts, say Georgetown Lombardi Comprehensive Cancer Center researchers.
A discovery by University at Buffalo biologists that may explain the evolution of a lethal toxin is providing new information that could lead to more effective treatments for humans who fall victim to it.
› Verified 2 days ago
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942903562 PECOS PAC ID: 8022927342 Enrollment ID: O20230615001995 |
News Archive
In this post in the Center for Global Development's (CGD) "Rethinking U.S. Foreign Assistance" blog, Connie Veillette, director of CGD's rethinking U.S. foreign assistance initiative, highlights two recent posts by CGD's Amanda Glassman and Nandini Oomman on the future of the Global Health Initiative.
For the most common form of childhood eye cancer, unilateral retinoblastoma, shortening the time from the first appearance of symptoms to diagnosis of disease has no bearing on survival or stage of the disease, according to a study by researchers at Columbia University Mailman School of Public Health in partnership with the Hospital Infantil de Mexico.
Alliance HealthCare Services, Inc.), a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced the acquisition of certain radiation therapy assets from Arkansas Cancer Center, P.A. The purchase price is expected to total approximately $9 million in cash and assumed indebtedness.
Women who receive palbociclib (Ibrance) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic neutropenia (BEN), can safely receive the drug without major concerns of developing infections associated with neutropenia, or low white blood cell counts, say Georgetown Lombardi Comprehensive Cancer Center researchers.
A discovery by University at Buffalo biologists that may explain the evolution of a lethal toxin is providing new information that could lead to more effective treatments for humans who fall victim to it.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brent Thomas Watson, MD 640 Westbrook Cir, Kaysville, UT 84037-1586 Ph: (801) 589-3177 | Brent Thomas Watson, MD 2132 N 1700 W Ste 230, Layton, UT 84041-7060 Ph: (801) 773-3900 |
News Archive
In this post in the Center for Global Development's (CGD) "Rethinking U.S. Foreign Assistance" blog, Connie Veillette, director of CGD's rethinking U.S. foreign assistance initiative, highlights two recent posts by CGD's Amanda Glassman and Nandini Oomman on the future of the Global Health Initiative.
For the most common form of childhood eye cancer, unilateral retinoblastoma, shortening the time from the first appearance of symptoms to diagnosis of disease has no bearing on survival or stage of the disease, according to a study by researchers at Columbia University Mailman School of Public Health in partnership with the Hospital Infantil de Mexico.
Alliance HealthCare Services, Inc.), a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced the acquisition of certain radiation therapy assets from Arkansas Cancer Center, P.A. The purchase price is expected to total approximately $9 million in cash and assumed indebtedness.
Women who receive palbociclib (Ibrance) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic neutropenia (BEN), can safely receive the drug without major concerns of developing infections associated with neutropenia, or low white blood cell counts, say Georgetown Lombardi Comprehensive Cancer Center researchers.
A discovery by University at Buffalo biologists that may explain the evolution of a lethal toxin is providing new information that could lead to more effective treatments for humans who fall victim to it.
› Verified 2 days ago
Norman C. Bos, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 | |
Bob Bohus Svagr, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 | |
Charles P Bean, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 | |
David A Cook, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 | |
Dr. John Charles Burrell, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 215 N 2300 E, Layton, UT 84040 Phone: 801-543-3312 | |
Dr. Craig Thomas Hatton, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2075 N 1200 W, Layton, UT 84041 Phone: 801-779-6200 |